Published in World J Urol on May 26, 2013
Trends in the placement of penile prostheses over the last 17 years in France. Asian J Androl (2015) 0.75
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc (2004) 1.64
EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology (1999) 1.52
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studies. J Sex Med (2011) 1.52
Should being aged over 70 years hinder penile prosthesis implantation? BJU Int (2009) 1.39
A survey of patients with inflatable penile prostheses: assessment of timing and frequency of intercourse and analysis of implant durability. J Sex Med (2012) 1.38
Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med (2007) 1.37
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med (2009) 1.28
Historical review of penile prosthesis design and surgical techniques: part 1 of a three-part review series on penile prosthetic surgery. J Sex Med (2009) 1.09
Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med (2010) 1.08
Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol (2001) 1.06
Sex after seventy: a pilot study of sexual function in older persons. J Sex Med (2007) 1.02
Determinants of patient satisfaction following penile prosthesis surgery. J Sex Med (2006) 0.98
A survey of patients with inflatable penile prostheses for satisfaction. J Urol (2005) 0.90
Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol (2004) 0.81
Penile prosthesis implantation: size matters. Eur Urol (2006) 0.80
Outcomes of and satisfaction with the inflatable penile prosthesis in the elderly male. Adv Urol (2012) 0.75
Fractured penis: diagnosis and management. J Sex Med (2009) 2.68
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology (2010) 2.19
Combined transurethral and laparoscopic partial cystectomy and robot-assisted bladder repair for the treatment of bladder endometrioma. J Minim Invasive Gynecol (2006) 1.92
Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol (2004) 1.76
Delayed penile rehabilitation post radical prostatectomy. J Sex Med (2010) 1.09
Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction. J Androl (2004) 1.09
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study. BJU Int (2011) 1.07
Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease. J Sex Med (2007) 0.96
Cryptorchidism and its impact on male fertility: a state of art review of current literature. Can Urol Assoc J (2011) 0.95
Minimizing morbidity in the treatment of penile melanoma: Mohs micrographic surgery and sentinel lymph node biopsy. Can J Urol (2007) 0.92
The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med (2011) 0.91
Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. BJU Int (2012) 0.90
Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications. Eur Urol (2007) 0.88
Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction? J Sex Med (2011) 0.87
Ca2+-activated Cl- channels in corpus cavernosum smooth muscle: a novel mechanism for control of penile erection. J Appl Physiol (1985) (2002) 0.87
Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol (2004) 0.86
Daily use of sildenafil improves endothelial function in men with type 2 diabetes. J Androl (2011) 0.85
Investigative models in erectile dysfunction: a state-of-the-art review of current animal models. J Sex Med (2011) 0.85
Clinical outcomes of intracavernosal injection in postprostatectomy patients: a single-center experience. Urology (2011) 0.84
Protein biomarker analysis of primary Peyronie's disease cells. J Sex Med (2009) 0.84
Regulation of intracellular Ca2+ release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP. Am J Physiol Cell Physiol (2004) 0.84
Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors. Can J Urol (2006) 0.83
Comparison between AMS 700™ CX and Coloplast™ Titan inflatable penile prosthesis for Peyronie's disease treatment and remodeling: clinical outcomes and patient satisfaction. J Sex Med (2012) 0.83
Minimally invasive intracorporeal incision of Peyronie's plaque: initial experiences with a new technique. Urology (2006) 0.82
Erectile dysfunction: monitoring response to treatment in clinical practice--recommendations of an international study panel. J Sex Med (2007) 0.82
Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. J Sex Med (2005) 0.82
Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. Eur Urol (2008) 0.81
Three-year outcomes of recovery of erectile function after open radical prostatectomy with sural nerve grafting. J Sex Med (2014) 0.79
Through the eyes of women: the partners' perspective on tadalafil. Urology (2006) 0.78
Peyronie's disease: evolving surgical management and the role of phosphodiesterase 5 inhibitors. ScientificWorldJournal (2009) 0.78
Surgery: centers of excellence for penile prosthesis: yes or no? Nat Rev Urol (2009) 0.78
Sexual dysfunction in 2011: advances in epidemiology, pathophysiology and treatment. Nat Rev Urol (2012) 0.77
Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction. Curr Urol Rep (2011) 0.77
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors. J Sex Med (2012) 0.77
Intracavernous pharmacotherapy for erectile dysfunction. Endocrine (2004) 0.77
Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions. Can J Plast Surg (2010) 0.76
Tadalafil in the treatment of erectile dysfunction. Curr Urol Rep (2003) 0.76
Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system. J Sex Med (2013) 0.76
Post-pyeloplasty flank pain treated with laparoscopically-assisted renal autotransplantation. Can J Urol (2004) 0.75
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health. J Am Acad Nurse Pract (2011) 0.75
Daily dosing of PDE5 inhibitors: where does it fit in? Curr Urol Rep (2013) 0.75